Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
Search
Close this search box.
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
Menu
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Molecular basis of human ES cell neurovascular differentiation and co-patterning

  • Post author:
  • Post published:May 9, 2025
  • Post category:

During human development, autonomic neurons align with and pattern alongside blood vessels. This patterning allows the autonomic nervous system to control the vascular function a phenomenon that is very useful…

Continue ReadingMolecular basis of human ES cell neurovascular differentiation and co-patterning

Investigation of synaptic defects in autism using patient-derived induced pluripotent stem cells

  • Post author:
  • Post published:May 9, 2025
  • Post category:

Autism spectrum disorders (ASD) are a group of neurodevelopmental diseases that occur in as many as 1 in 150 children in the United States. Three hallmarks of autism are dysfunctional…

Continue ReadingInvestigation of synaptic defects in autism using patient-derived induced pluripotent stem cells

Functional characterization of mutational load in nuclear reprogramming and differentiation

  • Post author:
  • Post published:May 9, 2025
  • Post category:

One of the most potentially powerful aspects of regenerative medicine is stem cell therapy. In this therapy, healthy tissues derived from stem cells will be implanted into patients with damaged…

Continue ReadingFunctional characterization of mutational load in nuclear reprogramming and differentiation

Phenotypic Analysis of Human ES Cell-Derived Muscle Stem Cells

  • Post author:
  • Post published:May 9, 2025
  • Post category:

We study human muscle development, and are actively investigating potential cell-based therapies for the treatment of degenerative muscle diseases, such as muscle dystrophy. This project will define the pathway that…

Continue ReadingPhenotypic Analysis of Human ES Cell-Derived Muscle Stem Cells

Triplet Repeat Instability in Human iPSCs

  • Post author:
  • Post published:May 9, 2025
  • Post category:

Over twenty human genetic diseases are caused by expansion of simple DNA sequences composed of repeats of three nucleotides (such as CAG, CTG, CGG and GAA) within essential genes. These…

Continue ReadingTriplet Repeat Instability in Human iPSCs

Neural and general splicing factors control self-renewal, neural survival and differentiation

  • Post author:
  • Post published:May 9, 2025
  • Post category:

Human embryonic and patient-specific induced pluripotent stem cells have the remarkable capacity to differentiate into many cell-types, including neurons, thus enabling the modeling of human neurological diseases in vitro, and…

Continue ReadingNeural and general splicing factors control self-renewal, neural survival and differentiation

Mechanisms of Direct Cardiac Reprogramming

  • Post author:
  • Post published:May 9, 2025
  • Post category:

Heart disease is a leading cause of adult and childhood mortality. The underlying pathology is typically loss of heart muscle cells that leads to heart failure, or improper development of…

Continue ReadingMechanisms of Direct Cardiac Reprogramming

Elucidating Molecular Basis of Hypertrophic Cardiomyopathy with Human Induced Pluripotent Stem Cells

  • Post author:
  • Post published:May 9, 2025
  • Post category:

Familial hypertrophic cardiomyopathy (HCM) is the leading cause of sudden cardiac death in young people, including trained athletes, and is the most common inherited heart defect. Until now, studies in…

Continue ReadingElucidating Molecular Basis of Hypertrophic Cardiomyopathy with Human Induced Pluripotent Stem Cells

Characterization and Engineering of the Cardiac Stem Cell Niche

  • Post author:
  • Post published:May 9, 2025
  • Post category:

Despite therapeutic advances, cardiovascular disease remains a leading cause of mortality and morbidity in both California and Europe. New insights into disease pathology, models to expedite in vitro testing and…

Continue ReadingCharacterization and Engineering of the Cardiac Stem Cell Niche

USP16 controls stem cell number: implications for Down Syndrome

  • Post author:
  • Post published:May 9, 2025
  • Post category:

Stem cells are endowed with the ability to self-renew, that means to give rise to other cells with the same potential to regenerate a tissue. Recently, we found a gene…

Continue ReadingUSP16 controls stem cell number: implications for Down Syndrome
  • Go to the previous page
  • 1
  • …
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • …
  • 65
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us